Speaker illustration

Professor Ilshat Gaisin

Izhevsk State Medical Academy, Izhevsk (Russian Federation)

Mothers with post-partum hypertension and kidney damage after pre-eclampsia should receive ACE inhibitors rather than methyldopa

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Cardiovascular Disease in Women

Session: Cardiovascular Disease in Special Populations ePosters

Thumbnail

Magnesium orotate for the treatment of heart failure in pregnant patients with unoperated atrial or ventricular septal defect

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Cardiovascular Pharmacotherapy, Other

Session: Pharmacology and Pharmacotherapy

Thumbnail

Magnesium orotate is a promising therapy for not closed atrial or ventricular septal defect in pregnant patients

Event: EuroPrevent 2018

Topic: Cardiovascular Disease in Special Populations, Other

Session: Cardiovascular disease in special populations

Thumbnail

Magnesium orotate for the treatment of preexisting hypertension and nondifferentiable connective tissue dysplasia in pregnant women

Event: EuroPrevent 2018

Topic: Cardiovascular Disease in Special Populations, Other

Session: Cardiovascular disease in special populations

Thumbnail

Indapamide sustained-release is safe and effective in the treatment of post partial hypertension: results from an observational, case-control 12-month study

Event: EuroPrevent 2018

Topic: Cardiovascular Disease in Special Populations, Other

Session: Cardiovascular disease in special populations

Thumbnail

Magnesium orotate improves symptoms, exercise capacity and quality of life in patients with valve prosthesis: results from a randomized, open-label, case-control 2-year study

Event: ESC CONGRESS 2016

Topic: Pharmacologic therapy

Session: Novel pharmacological therapy in chronic heart failure

Thumbnail

Magnesium orotate improves health-related quality of life after surgical valve replacement

Event: HEART FAILURE 2016

Topic: Valvular heart disease

Session: Valvular heart disease (diagnosis, management and interventional therapies)

Thumbnail

Magnesium orotate may be a new promising therapy of heart failure in operated valvular heart disease

Event: HEART FAILURE 2016

Topic: Valvular heart disease

Session: Valvular heart disease(diagnosis, management and interventional therapies)

Thumbnail

This platform is supported by

logo Novo Nordisk